Artal Group as of Sept. 30, 2022
Portfolio Holdings for Artal Group
Artal Group holds 131 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr Ser Tr S&p Biotech Call Option (XBI) | 16.9 | $397M | 5.0M | 79.32 | |
| Lexicon Pharmaceuticals Com New (LXRX) | 9.2 | $216M | 90M | 2.40 | |
| Beigene Sponsored Adr (BGNE) | 4.0 | $94M | 700k | 134.82 | |
| Mirati Therapeutics | 3.9 | $93M | 1.3M | 69.84 | |
| Apellis Pharmaceuticals (APLS) | 2.9 | $68M | 1.0M | 68.30 | |
| Bellus Health Com New | 2.7 | $63M | 6.0M | 10.56 | |
| Seagen | 2.6 | $62M | 450k | 136.83 | |
| Morphic Hldg (MORF) | 2.6 | $61M | 2.2M | 28.30 | |
| Scholar Rock Hldg Corp (SRRK) | 2.6 | $61M | 8.8M | 6.93 | |
| Springworks Therapeutics (SWTX) | 2.5 | $59M | 2.1M | 28.53 | |
| Fate Therapeutics (FATE) | 2.5 | $58M | 2.6M | 22.41 | |
| Ww Intl (WW) | 2.5 | $58M | 15M | 3.93 | |
| Igm Biosciences (IGMS) | 2.4 | $57M | 2.5M | 22.74 | |
| Cerevel Therapeutics Hldng I (CERE) | 2.4 | $57M | 2.0M | 28.26 | |
| Argenx Se Sponsored Adr (ARGX) | 2.3 | $53M | 150k | 353.05 | |
| Cytokinetics Com New (CYTK) | 2.1 | $49M | 1.0M | 48.45 | |
| Allovir (ALVR) | 1.9 | $44M | 5.6M | 7.89 | |
| Amicus Therapeutics (FOLD) | 1.8 | $42M | 4.0M | 10.44 | |
| Gossamer Bio (GOSS) | 1.7 | $39M | 3.2M | 11.98 | |
| Seer Com Cl A (SEER) | 1.6 | $37M | 4.8M | 7.74 | |
| Krystal Biotech (KRYS) | 1.5 | $35M | 500k | 69.70 | |
| Kymera Therapeutics (KYMR) | 1.4 | $33M | 1.5M | 21.77 | |
| Relay Therapeutics (RLAY) | 1.4 | $33M | 1.5M | 22.37 | |
| Sage Therapeutics (SAGE) | 1.3 | $29M | 750k | 39.16 | |
| Karuna Therapeutics Ord | 1.2 | $28M | 125k | 224.93 | |
| Erasca (ERAS) | 1.1 | $25M | 3.2M | 7.80 | |
| Iveric Bio | 1.0 | $22M | 1.3M | 17.94 | |
| Vigil Neuroscience (VIGL) | 0.9 | $21M | 2.3M | 9.10 | |
| Eqrx | 0.8 | $20M | 4.0M | 4.95 | |
| Denali Therapeutics (DNLI) | 0.8 | $18M | 600k | 30.69 | |
| Schrodinger (SDGR) | 0.7 | $18M | 700k | 24.98 | |
| Replimune Group (REPL) | 0.7 | $16M | 900k | 17.27 | |
| Intellia Therapeutics (NTLA) | 0.7 | $15M | 275k | 55.96 | |
| Kura Oncology (KURA) | 0.6 | $15M | 1.1M | 13.66 | |
| Generation Bio (GBIO) | 0.6 | $15M | 2.8M | 5.31 | |
| Mersana Therapeutics (MRSN) | 0.6 | $15M | 2.2M | 6.76 | |
| Foghorn Therapeutics (FHTX) | 0.6 | $15M | 1.7M | 8.58 | |
| Verve Therapeutics (VERV) | 0.6 | $14M | 400k | 34.35 | |
| Omega Therapeutics (OMGA) | 0.5 | $12M | 2.3M | 5.42 | |
| Wave Life Sciences SHS (WVE) | 0.5 | $11M | 3.0M | 3.61 | |
| Evotec Sponsored Ads (EVO) | 0.4 | $10M | 1.1M | 8.79 | |
| Sea Sponsored Ads (SE) | 0.4 | $9.7M | 173k | 56.05 | |
| Syros Pharmaceuticals Com New (SYRS) | 0.4 | $9.4M | 1.5M | 6.44 | |
| Alpine Immune Sciences (ALPN) | 0.4 | $8.6M | 1.2M | 7.20 | |
| Repare Therapeutics Ord (RPTX) | 0.4 | $8.5M | 700k | 12.13 | |
| Agenus Com New (AGEN) | 0.3 | $8.2M | 4.0M | 2.05 | |
| Selecta Biosciences (RNAC) | 0.3 | $8.0M | 4.9M | 1.64 | |
| Iteos Therapeutics (ITOS) | 0.3 | $7.6M | 400k | 19.05 | |
| Aurinia Pharmaceuticals (AUPH) | 0.3 | $7.5M | 1.0M | 7.52 | |
| Omega Alpha Spac Cl A | 0.3 | $7.4M | 750k | 9.93 | |
| Dyne Therapeutics (DYN) | 0.3 | $6.7M | 525k | 12.70 | |
| Y Mabs Therapeutics (YMAB) | 0.2 | $5.8M | 400k | 14.42 | |
| Ikena Oncology (IKNA) | 0.2 | $5.5M | 1.5M | 3.55 | |
| Talaris Therapeutics | 0.2 | $5.4M | 2.1M | 2.63 | |
| Kronos Bio (KRON) | 0.2 | $5.2M | 1.5M | 3.35 | |
| Lyell Immunopharma (LYEL) | 0.2 | $5.1M | 700k | 7.33 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.2 | $5.1M | 2.3M | 2.26 | |
| Recursion Pharmaceuticals In Cl A (RXRX) | 0.2 | $4.8M | 450k | 10.64 | |
| Alx Oncology Hldgs (ALXO) | 0.2 | $4.8M | 500k | 9.57 | |
| Ovid Therapeutics (OVID) | 0.2 | $4.6M | 2.5M | 1.84 | |
| Exscientia Ads (EXAI) | 0.2 | $4.5M | 550k | 8.21 | |
| Natera (NTRA) | 0.2 | $4.4M | 100k | 43.82 | |
| Avidity Biosciences Ord (RNA) | 0.2 | $4.1M | 250k | 16.33 | |
| Oatly Group Ab Sponsored Ads (OTLY) | 0.2 | $3.9M | 1.5M | 2.63 | |
| Concert Pharmaceuticals I equity | 0.2 | $3.8M | 573k | 6.70 | |
| Third Harmonic Bio (THRD) | 0.2 | $3.8M | 200k | 18.97 | |
| Mirion Technologies Com Cl A (MIR) | 0.2 | $3.7M | 500k | 7.47 | |
| Portage Fintech Acquisitn Class A Ord Shs (PFTA) | 0.2 | $3.7M | 380k | 9.77 | |
| Sqz Biotech (SQZB) | 0.2 | $3.7M | 1.6M | 2.28 | |
| Nanobiotix Sponsored Ads (NBTX) | 0.2 | $3.5M | 1.0M | 3.54 | |
| Leap Therapeutics | 0.2 | $3.5M | 4.0M | 0.88 | |
| I Mab Sponsored Ads (IMAB) | 0.1 | $3.4M | 850k | 4.01 | |
| Stoke Therapeutics (STOK) | 0.1 | $3.2M | 250k | 12.84 | |
| Cullinan Oncology (CGEM) | 0.1 | $3.2M | 250k | 12.82 | |
| Ac Immune Sa SHS (ACIU) | 0.1 | $3.2M | 1.0M | 3.16 | |
| Black Diamond Therapeutics (BDTX) | 0.1 | $2.8M | 1.6M | 1.69 | |
| Zymeworks | 0.1 | $2.8M | 450k | 6.15 | |
| Praxis Precision Medicines I | 0.1 | $2.7M | 1.2M | 2.27 | |
| Bridgebio Pharma (BBIO) | 0.1 | $2.5M | 250k | 9.94 | |
| Hookipa Pharma Inc equity (HOOK) | 0.1 | $2.5M | 1.8M | 1.34 | |
| Sana Biotechnology (SANA) | 0.1 | $2.4M | 400k | 6.00 | |
| Cyclerion Therapeutics | 0.1 | $2.4M | 2.8M | 0.86 | |
| Ambrx Biopharma Sponsored Ads | 0.1 | $2.3M | 2.2M | 1.08 | |
| Minerva Neurosciences Com New (NERV) | 0.1 | $2.3M | 250k | 9.23 | |
| Senti Biosciences Ord (SNTI) | 0.1 | $2.3M | 1.1M | 2.17 | |
| Fusion Pharmaceuticals (FUSN) | 0.1 | $2.3M | 750k | 3.01 | |
| Aptinyx | 0.1 | $2.3M | 6.1M | 0.37 | |
| Graphite Bio | 0.1 | $2.2M | 700k | 3.17 | |
| Immunic (IMUX) | 0.1 | $2.2M | 700k | 3.16 | |
| Vor Biopharma (VOR) | 0.1 | $2.2M | 550k | 3.98 | |
| Instil Bio | 0.1 | $2.2M | 450k | 4.84 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.1 | $2.0M | 1.0M | 1.93 | |
| Gritstone Oncology Ord (GRTS) | 0.1 | $1.9M | 750k | 2.57 | |
| 23andme Holding Class A Com (ME) | 0.1 | $1.9M | 661k | 2.86 | |
| 111 Ads (YI) | 0.1 | $1.8M | 686k | 2.68 | |
| Immutep Sponsored Ads (IMMP) | 0.1 | $1.6M | 1.0M | 1.56 | |
| Kinnate Biopharma (KNTE) | 0.1 | $1.5M | 125k | 11.95 | |
| Solid Biosciences | 0.1 | $1.4M | 3.0M | 0.47 | |
| Tcr2 Therapeutics Inc cs | 0.1 | $1.4M | 750k | 1.80 | |
| Xilio Therapeutics (XLO) | 0.1 | $1.3M | 450k | 2.91 | |
| Mereo Biopharma Group Spon Ads (MREO) | 0.1 | $1.3M | 1.5M | 0.86 | |
| Oric Pharmaceuticals (ORIC) | 0.1 | $1.3M | 400k | 3.20 | |
| Adagene Ads (ADAG) | 0.1 | $1.3M | 1.0M | 1.28 | |
| Axcella Health Inc equity | 0.1 | $1.2M | 713k | 1.71 | |
| Cardiff Oncology (CRDF) | 0.0 | $1.2M | 750k | 1.54 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.0 | $1.1M | 111k | 10.36 | |
| Caribou Biosciences (CRBU) | 0.0 | $1.1M | 105k | 10.55 | |
| Aravive | 0.0 | $1.1M | 1.3M | 0.82 | |
| Marinus Pharmaceuticals Com New (MRNS) | 0.0 | $1.0M | 157k | 6.65 | |
| Spero Therapeutics (SPRO) | 0.0 | $1.0M | 500k | 2.00 | |
| Harpoon Therapeutics | 0.0 | $970k | 1.0M | 0.97 | |
| Lava Therapeutics Nv SHS (LVTX) | 0.0 | $914k | 200k | 4.57 | |
| Curis Com New | 0.0 | $910k | 1.3M | 0.70 | |
| Orchard Therapeutics Spon Ads | 0.0 | $902k | 1.8M | 0.50 | |
| Rubius Therapeutics | 0.0 | $886k | 2.0M | 0.43 | |
| Avantor (AVTR) | 0.0 | $882k | 45k | 19.60 | |
| Olema Pharmaceuticals (OLMA) | 0.0 | $719k | 261k | 2.76 | |
| Neximmune | 0.0 | $666k | 1.2M | 0.56 | |
| Mink Therapeutics (INKT) | 0.0 | $611k | 290k | 2.11 | |
| Metacrine Ord | 0.0 | $449k | 925k | 0.49 | |
| Hippo Hldgs Com New (HIPO) | 0.0 | $445k | 24k | 18.54 | |
| Corvus Pharmaceuticals (CRVS) | 0.0 | $409k | 500k | 0.82 | |
| Mei Pharma Com New | 0.0 | $387k | 1.0M | 0.39 | |
| Applied Therapeutics (APLT) | 0.0 | $372k | 400k | 0.93 | |
| Adobe Systems Incorporated (ADBE) | 0.0 | $358k | 1.3k | 275.38 | |
| Yumanity Therapeutics | 0.0 | $341k | 217k | 1.57 | |
| Astria Therapeutics (ATXS) | 0.0 | $301k | 33k | 9.03 | |
| Contrafect Corp Com New | 0.0 | $252k | 1.5M | 0.17 | |
| Codiak Biosciences | 0.0 | $156k | 200k | 0.78 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.0 | $141k | 225k | 0.63 | |
| Sigilon Therapeutics | 0.0 | $139k | 276k | 0.50 |
